Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Merck & Co., Inc. MRK.PA
$108.00
На 18:01, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
274043520000.00000000
-
week52high
110.00
-
week52low
77.30
-
Revenue
59283000000
-
P/E TTM
68
-
Beta
0.35259500
-
EPS
4.77000000
-
Last Dividend
2.68000000
-
Next Earnings Date
01 авг 2023 г. в 12:00
Описание компании
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
SVB Leerink | Outperform | Outperform | 29 июл 2022 г. |
Morgan Stanley | Equal-Weight | Equal-Weight | 29 июл 2022 г. |
Barclays | Overweight | Overweight | 29 июл 2022 г. |
UBS | Neutral | Neutral | 18 июл 2022 г. |
Atlantic Equities | Overweight | Overweight | 13 июл 2022 г. |
Berenberg | Buy | Hold | 14 сент 2022 г. |
SVB Leerink | Outperform | Outperform | 12 сент 2022 г. |
Erste Group | Buy | Hold | 25 авг 2022 г. |
SVB Leerink | Outperform | Outperform | 30 сент 2022 г. |
Wells Fargo | Overweight | Overweight | 28 окт 2022 г. |
Truist Securities | Buy | Buy | 28 окт 2022 г. |
Morgan Stanley | Equal-Weight | Equal-Weight | 28 окт 2022 г. |
Barclays | Overweight | Overweight | 28 окт 2022 г. |
Morgan Stanley | Equal-Weight | Equal-Weight | 12 окт 2022 г. |
Guggenheim | Buy | Buy | 01 ноя 2022 г. |
Credit Suisse | Outperform | 18 ноя 2022 г. | |
B of A Securities | Buy | Neutral | 04 янв 2023 г. |
Wells Fargo | Overweight | Overweight | 03 янв 2023 г. |
Cantor Fitzgerald | Overweight | Overweight | 19 дек 2022 г. |
SVB Leerink | Outperform | Outperform | 23 янв 2023 г. |
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии